CONTINUE TO SITE
OR WAIT null SECS
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Personalized Treatments Hold Promise for Lymphoma Patients
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.
As lymphoma treatments become less cookie-cutter and more custom, the Leukemia & Lymphoma Society Chief Medical Officer Gwen Nichols, MD, shares how healthcare executives need to alter their approach to managing therapy regimens to increase cure rates and survivorship.